Annual report
7751.TEDINET S100T58N
Period2023-01-01 → 2023-12-31
Filed2024-03-28
StandardUS GAAP
ConsolidatedYes
Data checks11 of 11 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥4.18T | 2023-01-01 → 2023-12-31 | Cons. | Revenues US GAAP (5-year summary) |
| Revenue | ¥4.03T | 2022-01-01 → 2022-12-31 | Cons. | Revenues US GAAP (5-year summary) |
| Revenue | ¥3.51T | 2021-01-01 → 2021-12-31d | Cons. | Revenues US GAAP (5-year summary) |
| Revenue | ¥3.16T | 2020-01-01 → 2020-12-31d | Cons. | Revenues US GAAP (5-year summary) |
| Revenue | ¥3.59T | 2019-01-01 → 2019-12-31d | Cons. | Revenues US GAAP (5-year summary) |
| Profit before tax | ¥390.8bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss before tax US GAAP (5-year summary) |
| Profit before tax | ¥352.4bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss before tax US GAAP (5-year summary) |
| Profit before tax | ¥302.7bn | 2021-01-01 → 2021-12-31d | Cons. | Profit loss before tax US GAAP (5-year summary) |
| Profit before tax | ¥130.3bn | 2020-01-01 → 2020-12-31d | Cons. | Profit loss before tax US GAAP (5-year summary) |
| Profit before tax | ¥195.5bn | 2019-01-01 → 2019-12-31d | Cons. | Profit loss before tax US GAAP (5-year summary) |
| Net income (owners) | ¥264.5bn | 2023-01-01 → 2023-12-31 | Cons. | Net income loss attributable to owners of parent US GAAP (5-year summary) |
| Net income (owners) | ¥244.0bn | 2022-01-01 → 2022-12-31 | Cons. | Net income loss attributable to owners of parent US GAAP (5-year summary) |
| Net income (owners) | ¥214.7bn | 2021-01-01 → 2021-12-31d | Cons. | Net income loss attributable to owners of parent US GAAP (5-year summary) |
| Net income (owners) | ¥83.3bn | 2020-01-01 → 2020-12-31d | Cons. | Net income loss attributable to owners of parent US GAAP (5-year summary) |
| Net income (owners) | ¥125.0bn | 2019-01-01 → 2019-12-31d | Cons. | Net income loss attributable to owners of parent US GAAP (5-year summary) |
| Total assets | ¥5.42T | at 2023-12-31 | Cons. | Total assets US GAAP (5-year summary) |
| Total assets | ¥5.10T | at 2022-12-31 | Cons. | Total assets US GAAP (5-year summary) |
| Total assets | ¥4.75T | at 2021-12-31d | Cons. | Total assets US GAAP (5-year summary) |
| Total assets | ¥4.63T | at 2020-12-31d | Cons. | Total assets US GAAP (5-year summary) |
| Total assets | ¥4.77T | at 2019-12-31d | Cons. | Total assets US GAAP (5-year summary) |
| Equity (owners) | ¥3.35T | at 2023-12-31 | Cons. | Equity attributable to owners of parent US GAAP (5-year summary) |
| Equity (owners) | ¥3.11T | at 2022-12-31 | Cons. | Equity attributable to owners of parent US GAAP (5-year summary) |
| Equity (owners) | ¥2.87T | at 2021-12-31d | Cons. | Equity attributable to owners of parent US GAAP (5-year summary) |
| Equity (owners) | ¥2.58T | at 2020-12-31d | Cons. | Equity attributable to owners of parent US GAAP (5-year summary) |
| Equity (owners) | ¥2.69T | at 2019-12-31d | Cons. | Equity attributable to owners of parent US GAAP (5-year summary) |
| Cash & equivalents | ¥401.3bn | at 2023-12-31 | Cons. | Cash and cash equivalents US GAAP (5-year summary) |
| Cash & equivalents | ¥362.1bn | at 2022-12-31 | Cons. | Cash and cash equivalents US GAAP (5-year summary) |
| Cash & equivalents | ¥401.4bn | at 2021-12-31d | Cons. | Cash and cash equivalents US GAAP (5-year summary) |
| Cash & equivalents | ¥407.7bn | at 2020-12-31d | Cons. | Cash and cash equivalents US GAAP (5-year summary) |
| Cash & equivalents | ¥412.8bn | at 2019-12-31d | Cons. | Cash and cash equivalents US GAAP (5-year summary) |
| Operating cash flow | ¥451.2bn | 2023-01-01 → 2023-12-31 | Cons. | Cash flows from used in operating activities US GAAP (5-year summary) |
| Operating cash flow | ¥262.6bn | 2022-01-01 → 2022-12-31 | Cons. | Cash flows from used in operating activities US GAAP (5-year summary) |
| Operating cash flow | ¥451.0bn | 2021-01-01 → 2021-12-31d | Cons. | Cash flows from used in operating activities US GAAP (5-year summary) |
| Operating cash flow | ¥333.8bn | 2020-01-01 → 2020-12-31d | Cons. | Cash flows from used in operating activities US GAAP (5-year summary) |
| Operating cash flow | ¥358.5bn | 2019-01-01 → 2019-12-31d | Cons. | Cash flows from used in operating activities US GAAP (5-year summary) |
| Investing cash flow | −¥275.4bn | 2023-01-01 → 2023-12-31 | Cons. | Cash flows from used in investing activities US GAAP (5-year summary) |
| Investing cash flow | −¥180.8bn | 2022-01-01 → 2022-12-31 | Cons. | Cash flows from used in investing activities US GAAP (5-year summary) |
| Investing cash flow | −¥207.3bn | 2021-01-01 → 2021-12-31d | Cons. | Cash flows from used in investing activities US GAAP (5-year summary) |
| Investing cash flow | −¥155.4bn | 2020-01-01 → 2020-12-31d | Cons. | Cash flows from used in investing activities US GAAP (5-year summary) |
| Investing cash flow | −¥228.6bn | 2019-01-01 → 2019-12-31d | Cons. | Cash flows from used in investing activities US GAAP (5-year summary) |
| Financing cash flow | −¥156.7bn | 2023-01-01 → 2023-12-31 | Cons. | Cash flows from used in financing activities US GAAP (5-year summary) |
| Financing cash flow | −¥146.8bn | 2022-01-01 → 2022-12-31 | Cons. | Cash flows from used in financing activities US GAAP (5-year summary) |
| Financing cash flow | −¥267.4bn | 2021-01-01 → 2021-12-31d | Cons. | Cash flows from used in financing activities US GAAP (5-year summary) |
| Financing cash flow | −¥183.4bn | 2020-01-01 → 2020-12-31d | Cons. | Cash flows from used in financing activities US GAAP (5-year summary) |
| Financing cash flow | −¥232.6bn | 2019-01-01 → 2019-12-31d | Cons. | Cash flows from used in financing activities US GAAP (5-year summary) |
| EPS (basic) | ¥264.2 | 2023-01-01 → 2023-12-31 | Cons. | Basic earnings loss per share US GAAP (5-year summary) |
| EPS (basic) | ¥236.71 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share US GAAP (5-year summary) |
| EPS (basic) | ¥205.35 | 2021-01-01 → 2021-12-31d | Cons. | Basic earnings loss per share US GAAP (5-year summary) |
| EPS (basic) | ¥79.37 | 2020-01-01 → 2020-12-31d | Cons. | Basic earnings loss per share US GAAP (5-year summary) |
| EPS (basic) | ¥116.79 | 2019-01-01 → 2019-12-31d | Cons. | Basic earnings loss per share US GAAP (5-year summary) |
| EPS (diluted) | ¥264.08 | 2023-01-01 → 2023-12-31 | Cons. | Diluted earnings loss per share US GAAP (5-year summary) |
| EPS (diluted) | ¥236.63 | 2022-01-01 → 2022-12-31 | Cons. | Diluted earnings loss per share US GAAP (5-year summary) |
| EPS (diluted) | ¥205.29 | 2021-01-01 → 2021-12-31d | Cons. | Diluted earnings loss per share US GAAP (5-year summary) |
| EPS (diluted) | ¥79.35 | 2020-01-01 → 2020-12-31d | Cons. | Diluted earnings loss per share US GAAP (5-year summary) |
| EPS (diluted) | ¥116.77 | 2019-01-01 → 2019-12-31d | Cons. | Diluted earnings loss per share US GAAP (5-year summary) |
| Net assets per share | ¥3,394.92 | at 2023-12-31 | Cons. | Equity attributable to owners of parent per share US GAAP (5-year summary) |
| Net assets per share | ¥3,065.97 | at 2022-12-31 | Cons. | Equity attributable to owners of parent per share US GAAP (5-year summary) |
| Net assets per share | ¥2,748.36 | at 2021-12-31d | Cons. | Equity attributable to owners of parent per share US GAAP (5-year summary) |
| Net assets per share | ¥2,462.65 | at 2020-12-31d | Cons. | Equity attributable to owners of parent per share US GAAP (5-year summary) |
| Net assets per share | ¥2,524.36 | at 2019-12-31d | Cons. | Equity attributable to owners of parent per share US GAAP (5-year summary) |
| Equity ratio | 61.9% | at 2023-12-31 | Cons. | Equity to asset ratio US GAAP (5-year summary) |
| Equity ratio | 61.1% | at 2022-12-31 | Cons. | Equity to asset ratio US GAAP (5-year summary) |
| Equity ratio | 60.5% | at 2021-12-31d | Cons. | Equity to asset ratio US GAAP (5-year summary) |
| Equity ratio | 55.7% | at 2020-12-31d | Cons. | Equity to asset ratio US GAAP (5-year summary) |
| Equity ratio | 56.3% | at 2019-12-31d | Cons. | Equity to asset ratio US GAAP (5-year summary) |
| ROE | 8.2% | 2023-01-01 → 2023-12-31 | Cons. | Rate of return on equity US GAAP (5-year summary) |
| ROE | 8.1% | 2022-01-01 → 2022-12-31 | Cons. | Rate of return on equity US GAAP (5-year summary) |
| ROE | 7.9% | 2021-01-01 → 2021-12-31d | Cons. | Rate of return on equity US GAAP (5-year summary) |
| ROE | 3.2% | 2020-01-01 → 2020-12-31d | Cons. | Rate of return on equity US GAAP (5-year summary) |
| ROE | 4.5% | 2019-01-01 → 2019-12-31d | Cons. | Rate of return on equity US GAAP (5-year summary) |
| Employees | 169,151 | at 2023-12-31 | Cons. | Number of employees |
| Employees | 180,775 | at 2022-12-31 | Cons. | Number of employees |
| Employees | 184,034 | at 2021-12-31d | Cons. | Number of employees |
| Employees | 181,897 | at 2020-12-31d | Cons. | Number of employees |
| Employees | 187,041 | at 2019-12-31d | Cons. | Number of employees |
| Revenue | ¥1.67T | 2023-01-01 → 2023-12-31 | Standalone | Net sales |
| Revenue | ¥1.74T | 2022-01-01 → 2022-12-31 | Standalone | Net sales |
| Revenue | ¥1.51T | 2021-01-01 → 2021-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.26T | 2020-01-01 → 2020-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.54T | 2019-01-01 → 2019-12-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥134.2bn | 2023-01-01 → 2023-12-31 | Standalone | Operating income |
| Operating income | ¥120.8bn | 2022-01-01 → 2022-12-31 | Standalone | Operating income |
| Ordinary income | ¥511.6bn | 2023-01-01 → 2023-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥214.3bn | 2022-01-01 → 2022-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥248.0bn | 2021-01-01 → 2021-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥40.5bn | 2020-01-01 → 2020-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥102.0bn | 2019-01-01 → 2019-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥511.6bn | 2023-01-01 → 2023-12-31 | Standalone | Income before income taxes |
| Profit before tax | ¥218.0bn | 2022-01-01 → 2022-12-31 | Standalone | Income before income taxes |
| Net income | ¥476.8bn | 2023-01-01 → 2023-12-31 | Standalone | Profit loss |
| Net income | ¥193.6bn | 2022-01-01 → 2022-12-31 | Standalone | Profit loss |
| Net income | ¥228.0bn | 2021-01-01 → 2021-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥42.8bn | 2020-01-01 → 2020-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥90.2bn | 2019-01-01 → 2019-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥2.94T | at 2023-12-31 | Standalone | Assets |
| Total assets | ¥2.91T | at 2022-12-31 | Standalone | Assets |
| Total assets | ¥2.82T | at 2021-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥2.86T | at 2020-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥2.93T | at 2019-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥1.35T | at 2023-12-31 | Standalone | Liabilities |
| Total liabilities | ¥1.57T | at 2022-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.59T | at 2023-12-31 | Standalone | Net assets |
| Net assets / equity | ¥1.34T | at 2022-12-31 | Standalone | Net assets |
| Net assets / equity | ¥1.37T | at 2021-12-31d | Standalone | Net assets |
| Net assets / equity | ¥1.23T | at 2020-12-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥1.36T | at 2019-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥43.8bn | at 2023-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥33.2bn | at 2022-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥476.12 | 2023-01-01 → 2023-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥187.84 | 2022-01-01 → 2022-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥218.02 | 2021-01-01 → 2021-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥40.81 | 2020-01-01 → 2020-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥84.27 | 2019-01-01 → 2019-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥475.92 | 2023-01-01 → 2023-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥187.78 | 2022-01-01 → 2022-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥217.96 | 2021-01-01 → 2021-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥40.8 | 2020-01-01 → 2020-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥84.26 | 2019-01-01 → 2019-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥140 | 2023-01-01 → 2023-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥120 | 2022-01-01 → 2022-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥100 | 2021-01-01 → 2021-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥80 | 2020-01-01 → 2020-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥160 | 2019-01-01 → 2019-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,610.54 | at 2023-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,319.84 | at 2022-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,307.1 | at 2021-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,171.59 | at 2020-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,276.73 | at 2019-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 54.1% | at 2023-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.0% | at 2022-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 48.5% | at 2021-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.9% | at 2020-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.4% | at 2019-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 32.5% | 2023-01-01 → 2023-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 14.3% | 2022-01-01 → 2022-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 17.6% | 2021-01-01 → 2021-12-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 3.3% | 2020-01-01 → 2020-12-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.3% | 2019-01-01 → 2019-12-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 1,333,763,464 | at 2023-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,333,763,464 | at 2022-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,333,763,464 | at 2021-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,333,763,464 | at 2020-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,333,763,464 | at 2019-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 23,931 | at 2023-12-31 | Standalone | Number of employees |
| Employees | 24,717 | at 2022-12-31 | Standalone | Number of employees |
| Employees | 25,377 | at 2021-12-31d | Standalone | Number of employees |
| Employees | 25,713 | at 2020-12-31d | Standalone | Number of employees |
| Employees | 25,740 | at 2019-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 8
| Segment | Item | Period | Value |
|---|---|---|---|
| Imaging Business Unitreportable segment | employees | at 2023-12-31 | 26077 pure |
| Industry Business Unitreportable segment | employees | at 2023-12-31 | 8126 pure |
| Medical Business Unitreportable segment | employees | at 2023-12-31 | 13149 pure |
| Printing Business Unitreportable segment | employees | at 2023-12-31 | 109695 pure |
| Imaging Business Unitreportable segment | employees | at 2023-12-31 | 4252 pure |
| Industry Business Unitreportable segment | employees | at 2023-12-31 | 2513 pure |
| Medical Business Unitreportable segment | employees | at 2023-12-31 | 373 pure |
| Printing Business Unitreportable segment | employees | at 2023-12-31 | 9556 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,117
| Item | Context | Value | Unit |
|---|---|---|---|
| Total shareholder return | Prior3YearInstant_NonConsolidatedMember | 0.739 | |
| Total shareholder return | Prior2YearInstant_NonConsolidatedMember | 1.047 | |
| Total shareholder return | Prior1YearInstant_NonConsolidatedMember | 1.105 | |
| Total shareholder return | CurrentYearInstant_NonConsolidatedMember | 1.406 | |
| Total return on share price index | Prior4YearInstant_NonConsolidatedMember | 1.178 | |
| Total return on share price index | Prior3YearInstant_NonConsolidatedMember | 1.257 | |
| Total return on share price index | Prior2YearInstant_NonConsolidatedMember | 1.410 | |
| Total return on share price index | Prior1YearInstant_NonConsolidatedMember | 1.375 | |
| Total return on share price index | CurrentYearInstant_NonConsolidatedMember | 1.728 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E02274-000PrintingBusinessUnitReportableSegmentsMember | 109695 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E02274-000MedicalBusinessUnitReportableSegmentsMember | 13149 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E02274-000ImagingBusinessUnitReportableSegmentsMember | 26077 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E02274-000IndustryBusinessUnitReportableSegmentsMember | 8126 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E02274-000OtherAndCorporateMember | 12104 | |
| Number of employees | CurrentYearInstant | 169151 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 23931 | |
| Average age years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 44.1 | |
| Average length of service years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 19.0 | |
| Average annual salary information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 8324359 | JPY |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E02274-000PrintingBusinessUnitReportableSegmentsMember | 9556 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E02274-000MedicalBusinessUnitReportableSegmentsMember | 373 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E02274-000ImagingBusinessUnitReportableSegmentsMember | 4252 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E02274-000IndustryBusinessUnitReportableSegmentsMember | 2513 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E02274-000OtherAndCorporateMember | 7237 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 23931 | |
| Research and development expenses research and development activities | CurrentYearDuration | 331914000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E02274-000PrintingBusinessUnitReportableSegmentsMember | 97925000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E02274-000MedicalBusinessUnitReportableSegmentsMember | 47182000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E02274-000ImagingBusinessUnitReportableSegmentsMember | 93834000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E02274-000IndustryBusinessUnitReportableSegmentsMember | 27872000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E02274-000PrintingBusinessUnitReportableSegmentsMember | 62258000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E02274-000MedicalBusinessUnitReportableSegmentsMember | 11272000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E02274-000ImagingBusinessUnitReportableSegmentsMember | 27420000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E02274-000IndustryBusinessUnitReportableSegmentsMember | 9032000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E02274-000OtherAndCorporateMember | 91158000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration | 201140000000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 1333763464 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 1333763464 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 1333763464 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 1333763464 | |
| Number of shares constituting one unit | CurrentYearInstant_OrdinaryShareMember | 100 | |
| Number of shareholders national and local governments | CurrentYearInstant_OrdinaryShareMember | 1 | |
| Number of shareholders financial institutions | CurrentYearInstant_OrdinaryShareMember | 189 | |
| Number of shareholders financial service providers | CurrentYearInstant_OrdinaryShareMember | 61 | |
| Number of shareholders other corporations | CurrentYearInstant_OrdinaryShareMember | 2478 | |
| Number of shareholders foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 945 | |
| Number of shareholders foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 432 | |
| Number of shareholders individuals and others | CurrentYearInstant_OrdinaryShareMember | 369111 | |
| Number of shareholders total | CurrentYearInstant_OrdinaryShareMember | 373217 | |
| Number of shares held number of units national and local governments | CurrentYearInstant_OrdinaryShareMember | 30 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 11 of 11 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |